SEC Form 4 · accession 0001127602-15-008899
UNITED THERAPEUTICS Corp · UTHR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tommy G Thompson
Director
Period of report
Feb 27, 2015
Accepted (ET)
Feb 27, 2015 · 8:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 27, 2015 | M | 7,500 | $52.65 | A | 7,500 | D | |
| Common StockF1 | Feb 27, 2015 | S | 3,650 | $152.73 | D | 3,850 | D | |
| Common StockF2 | Feb 27, 2015 | S | 1,350 | $153.90 | D | 2,500 | D | |
| Common StockF3 | Feb 27, 2015 | S | 2,300 | $154.80 | D | 200 | D | |
| Common StockF4 | Feb 27, 2015 | S | 200 | $154.84 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options | $52.65 | Feb 27, 2015 | M | 7,500 | D | Jan 1, 2011 | Jan 1, 2020 | Common Stock | 7,500 | 20,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $152.48 to $153.09. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $153.50 to $154.27. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3This transaction was executed in multiple trades at prices ranging from $154.76 to $154.81. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F4This transaction was executed in multiple trades at prices ranging from $154.82 to $154.86. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.